COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,428,000 | -14.9% | 188,094 | +5.2% | 0.01% | -13.3% |
| Q4 2021 | $2,853,000 | +142550.0% | 178,748 | +162398.2% | 0.02% | – |
| Q2 2021 | $2,000 | -95.6% | 110 | -96.5% | 0.00% | – |
| Q1 2021 | $45,000 | -16.7% | 3,105 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | -5.3% | 3,105 | 0.0% | 0.00% | – |
| Q3 2020 | $57,000 | +3.6% | 3,105 | 0.0% | 0.00% | – |
| Q2 2020 | $55,000 | -89.2% | 3,105 | -90.1% | 0.00% | -100.0% |
| Q1 2020 | $509,000 | -88.3% | 31,382 | -87.0% | 0.00% | -80.0% |
| Q4 2019 | $4,346,000 | +677.5% | 241,371 | +774.1% | 0.02% | +566.7% |
| Q3 2019 | $559,000 | -61.9% | 27,614 | -47.0% | 0.00% | -57.1% |
| Q4 2016 | $1,468,000 | +7626.3% | 52,138 | +6204.5% | 0.01% | – |
| Q4 2015 | $19,000 | -58.7% | 827 | -63.7% | 0.00% | – |
| Q3 2015 | $46,000 | +142.1% | 2,281 | +239.9% | 0.00% | – |
| Q2 2015 | $19,000 | -98.8% | 671 | -98.8% | 0.00% | -100.0% |
| Q1 2015 | $1,642,000 | +245.7% | 53,681 | +84.4% | 0.01% | +300.0% |
| Q4 2014 | $475,000 | – | 29,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |